patient care

6:41
Supportive care and prophylaxis of the side effects of myeloma drugs
Heinz Ludwig
2:09
May the EuroCAR-T Force be with you: improving CAR-T patient care
Victoria Metaxa
2:04
Emerging therapies in AML: why patients should be optimistic
Naval Daver
3:08
CAR T-cell therapy: the patient’s perspective
Bregje Verhoeven
4:03
Communication between CLL patients and doctors
Ben Kennedy
3:42
Transitional care priorities for teenagers/young adults with SCD and chronic diseases
Subarna Chakravorty
1:03
Multiple myeloma: what needs to change to improve care?
Tanya Burton
2:18
Self-administration of bortezomib in multiple myeloma: results from Cardiff
Tanya Burton
1:27
Update on CLL research at Memorial Sloan Kettering
Anthony Mato
0:57
The role of the nurse in ensuring QoL in CAR T-cell patients
Lissa Gray
3:06
Personalizing survivorship care
Navneet Majhail
1:12
The EBMT Nurses Group and the patient advocacy track
John Murray
1:14
The evolution of patient advocacy
Jan Geissler
1:28
The importance of patient advocacy tracks at congresses
Jan Geissler
0:53
The aims of the Patvocates Network
Jan Geissler
1:08
Current challenges in myeloma therapy
Karthik Ramasamy
VJHemOnc VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

The content of VJHemOnc is intended for healthcare professionals